NewSpring Capital leads financing for cell therapy CDMO merger Kincellis
Kincellis Advanced Therapies is a US-based contract development and manufacturing organization for cell and advanced-therapy modalities, operating roughly 140,000 square feet of GMP manufacturing space across Florida, North Carolina and Texas. The post NewSpring Capital leads financing for cell therapy CDMO merger Kincellis appeared first on PE Hub .
We haven't written up this one. PE Hub has the full story — the link below goes straight to it.
